Cargando…
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
In a nationwide study of 3818 charts from patients with fatal COVID-19, we found that geographical differences in Dipeptidyl peptidase 4 (DPP4) inhibitors use did not correlate with diabetes prevalence among COVID-19 deaths, thus not supporting the hypothesis of a clinically relevant involvement of...
Autores principales: | Strollo, Rocky, Maddaloni, Ernesto, Dauriz, Marco, Pedone, Claudio, Buzzetti, Raffaella, Pozzilli, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492144/ https://www.ncbi.nlm.nih.gov/pubmed/32946854 http://dx.doi.org/10.1016/j.diabres.2020.108444 |
Ejemplares similares
-
Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement
por: Maddaloni, Ernesto, et al.
Publicado: (2015) -
One size does not fit all glycemic targets for type 2 diabetes
por: Pozzilli, Paolo, et al.
Publicado: (2014) -
Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
por: Napoli, Nicola, et al.
Publicado: (2013) -
Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes
por: D'Onofrio, Luca, et al.
Publicado: (2021) -
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism
por: Mahrooz, Abdolkarim, et al.
Publicado: (2021)